ARCHIVES

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

This article is from The Cancer Letter archive.

Vol. 20 No. 08 | February 25, 1994

Download PDF Visit The Full Archive

Related Articles

Scientific Opportunity Should Guide Fund Allocation, House Says

August 4, 1995

NCI Officials Open To Fine-Tuning Group Budgets As Advocates Chip Away At NCTN’s Façade

May 2, 2014

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

Obama Picks Hamburg for FDA Commissioner

March 20, 2009

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013

CAB Reluctantly Approves Use Of Contract To Support Cancer Journals

February 15, 1985